Evommune, Inc.

EVMN·NYSE·$23.35Share Price as of 11/2·$331MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/05/26 10-QQ3 ended 09/30/2512/11/25

Disclosures

8-KCurrent report10/01/26 8-KRegulation FD Disclosure09/23/26 8-KRegulation FD Disclosure09/15/26 8-KRegulation FD Disclosure; Other Events09/09/26 8-KResults of Operations08/06/26

Prospectuses and Registrations

424B3Prospectus09/09/26 424B3Prospectus08/06/26 424B3Prospectus06/29/26 424B3Prospectus06/02/26 424B3Prospectus05/07/26

Proxies

DEF 14ADefinitive proxy04/21/26 DEFA14AAdditional proxy materials04/21/26

Ownership

Form 4Insider transaction10/15/26 SC 13GBeneficial ownership08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 SC 13GBeneficial ownership07/16/26 Form 4Insider transaction07/10/26

Other

EFFECTRequest for effectiveness04/24/26 CORRESPCorrespondence with the SEC04/22/26 UPLOADLetter from the SEC04/22/26 ARSAnnual report to shareholders04/21/26 CERTCEO/CFO certification11/05/25